Only ZEGERID offers a unique pharmacokinetic profile with
immediate release technology
Print Executive Summary.
ZEGERID® (omeprazole/sodium bicarbonate) has a Unique Pharmacokinetic Profile. Delayed-release omeprazole products or formulations are not therapeutically equivalent to ZEGERID.
- ZEGERID is not interchangeable with Prilosec®, Prilosec OTC®, or generic omeprazole.1
- There are no AB-rated generic equivalents to ZEGERID according to the FDA Orange Book.2
- All other oral PPIs are delayed-release and require enteric coatings that delay absorption and initial acid suppression3-8
Only ZEGERID has a built-in buffer to protect the omeprazole, allowing for rapid absorption in ~30 minutes. Learn more about the Unique Immediate Release Technology of ZEGERID.
Next page: Ordering ZEGERID
References
- ZEGERID Prescribing Information. Santarus, Inc. April 26, 2007.
- FDA Web site. Electronic Orange Book. Available at: www.fda.gov/cder/ob/default.htm.
Accessed September 5, 2007. - Castell D Review of immediate-release omeprazole for the treatment of gastric acid-related disorders.
Expert Opin Pharmacother. 2005;6;2501-2510. - Aciphex Prescribing Information. Eisai Inc. and Janssen Pharmaceutica Inc. August 2003.
- Nexium Prescribing Information. AstraZeneca. October 2006.
- Prevacid Prescribing Information. TAP Pharmaceutical Products, Inc. September 2006.
- Prilosec Prescribing Information. AstraZeneca. September 2006.
- Protonix Prescribing Information. Wyeth Pharmaceuticals, Inc. April 2007.

